Tuesday, October 28, 2008

7:00 PM-10:00 PM

Symposium 1 (open)

Founders of the Research Initiative Symposium: Genetics and Child & Adolescent Psychiatry: Dynamic Interplay of Phenotype, Genotype, and Treatment Sponsored by the AACAP Work Group on Research

Wednesday, October 29, 2008

8:00 AM-11:00 AM

Symposium 2 (open)

A Community Study of Children with ADHD: Prevalence by Race, Comorbidity, Health Risk Behaviors, and Parenting Steven P. Cuffe, M.D.

Symposium 3 (open)

Comprehensive Behavioral Intervention for Tics (CBITS) Study: Background and Outcomes

Symposium 4 (open)

Differential Diagnosis of Pediatric Bipolar Disorder: What Can We Learn from Recent Research? Boris Birmaher, M.D.

Symposium 5 (open)

Evidence-Based Practices and Clinical Practice Evidence: Bridging the Gap

Symposium 6 (open)

The Neural Bases of Normal Emotional and Cognitive Processes Bradley S. Peterson, M.D.

1:00 PM-4:00 PM

Symposium 7 (open)

Bipolar Disorder Outcome – Different Ages Different Stages Gabrielle A. Carlson, M.D.

Symposium 8 (open)

Girls in the Juvenile Justice System: Health Disparities in Substance Abuse and HIV/Sexually Transmitted Infection Risk

Symposium 9 (open)

Public Health Model for Child Psychiatry: Cost Implications Katherine E. Grimes, M.D., M.P.H.

Symposium 10 (open)

Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Benedetto Vitiello, M.D.

Thursday, October 30, 2008

8:00 AM-11:00 AM

Symposium 11 (open)

Longitudinal Studies of Preschool Psychopathology Adrian Angold, M.R.C.Psych.

Symposium 12 (open)

More Than Counting: Contributions of Epidemiology to Child Psychiatry

Symposium 13 (open)

Special Pharmacotherapy Considerations in the Treatment of Pediatric ADHD Timothy Wilens, M.D.

Symposium 14 (open)

Tobacco Use and Treatment: Issues for Child Mental Health Catherine A. Martin, M.D. Sponsored by the AACAP Substance Abuse and Addiction Committee

Symposium 15 (open)

The Fate of Holocaust Memories: Transmission and Family Dialogues

1:30 PM-4:30 PM

Symposium 16 (open)

Advances in the Treatment of Adolescents with Marijuana Dependence

Symposium 17 (open)

The American Heart Association Advisory on Cardiovascular Monitoring for ADHD Treatment: Issues and Final Statement Laurence L. Greenhill, M.D.

Symposium 18 (open)

Child Adolescent Anxiety Multimodal Study (CAMS)

Symposium 19 (open)

New Research on Etiological Mechanisms and Clinical Significance of Sleep Problems in ADHD Margaret D. Weiss, M.D.

Symposium 20 (open)

Substance Use Predicts HIV Infection in Adolescents Sponsored by the AACAP HIV Issues Committee and Substance Abuse and Addiction Committee

Friday, October 31, 2008

8:30 AM-11:30 AM

Symposium 21 (open)

An Examination of Subthreshold Psychopathologies in Children and Adolescents

Symposium 22 (open)

Psychotropic Induced Weight Gain in Children and Adolescents: A Multidisciplinary Approach

Symposium 23 (open)

Latest Advances in Child Bipolar Disorder Barbara Geller, M.D. Sponsored by the Child and Adolescent Bipolar Foundation

Symposium 24 (open)

RUPP-PI Autism Network: Risperidone with or without Parent Management Training in Children and Adolescents with Pervasive Developmental Disorders Christopher J. McDougle, M.D.

Symposium 25 (open)

The Opioid Dependent Adolescent/Young Adult: Clinical Characteristics, Effectiveness of a Multicenter Opioid Agonist Treatment Study, and Practice Adoption at a Community Program Geetha A. Subramaniam, M.D. Sponsored by the AACAP Substance Abuse and Addiction Committee

1:00 PM-4:00 PM

Symposium 26 (open)

Challenges to Child Psychiatric Clinical Trials Success Joan Busner, Ph.D.

Symposium 27 (open)

Effects of Stimulant Treatment of ADHD in Childhood and Adolescence and Subsequent Drug Abuse in Adulthood ADHD

Symposium 28 (open)

Real World Outcomes of Child and Adolescent Psychiatric Disorders Elizabeth J. Costello, Ph.D.

Symposium 29 (open)

Simon Wile Symposium: Pediatric Psychosomatic Medicine - Problems and Predicaments David R. DeMaso, M.D. Sponsored by the AACAP Committee on Collaboration with Medical Professions

Symposium 30 (open)

Weighing Risks and Benefits of Psychotropic Treatments in Children and Adolescents Christoph U. Correll, M.D.

Symposium 31 (open)

From Mental Disorder to Iatrogenic Hypogonadism: Dilemmas in Conceptualizing Gender Identity Disorder (GID) as a Psychiatric Condition Heino F. L. Meyer-Bahlburg

Saturday, November 1, 2008

8:00 AM-11:00 AM

Symposium 32 (open)

New Evidence for Revisiting Epilepsy as a Developmental Neuropsychiatric Disorder Sigita Plioplys, M.D. Sponsored by the AACAP Committee on Collaboration with Medical Professions

Symposium 33 (open)

Pediatric Bipolar Collaborative Trial of Lithium Versus Divalproex Robert A. Kowatch, M.D., Ph.D.

Symposium 34 (open)

The Role of Frontostriatal Circuits in Childhood Psychopathologies Bradley S. Peterson, M.D.

Symposium 35 (open)

European Perspectives on an Endophenotype for ADHD Joseph A. Sergeant, Ph.D.

Symposium 36 (open)

Anabolic Steroids and Other Performance Enhancing Drugs in Children, Adolescents, and Young Adults: Clinical, Sociological, and Ethical Considerations Gary R. Gaffney, M.D.

1:00 PM-4:00 PM

Symposium 37 (open)

Monitoring Medication Trends in High Risk Youth Katherine E. Grimes, M.D., M.P.H.

Symposium 38 (open)

Children at Risk for Bipolar Disorder: From Clinical Phenotypes to Neurobiology Boris Birmaher, M.D.

Symposium 39 (open)

Functional and Adaptive Behavior Outcomes in ADHD: Defining and Understanding the Role of Impairment Jeffrey Newcorn, M.D.

Symposium 40 (open)

Treatment of Repetitive Behavior in Autism Spectrum Disorders: Results of the NIH STAART Psychopharmacology Network Trial

Sunday, November 2, 2008

8:00 AM-11:00 AM

Symposium 41 (open)

How to Help Silent Children: Assessment and Treatment of Children with Selective Mutism Hanne Kristensen, M.D., Ph.D.

Symposium 42 (open)

An Overview of Working Memory in ADHD Margaret D. Weiss, M.D.

Symposium 43 (open)

Transforming Systems: Elephants Can Dance John Hamilton, M.D., M.S.